136 related articles for article (PubMed ID: 35093991)
1. Orbital Exenteration for Advanced Periocular Adnexal Malignancies: Curative Versus Palliative Surgical Intent.
Malik M; Vahdani K; Rose GE; Daniel C; Uddin JM; Verity DH; Collin JRO
Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):387-392. PubMed ID: 35093991
[TBL] [Abstract][Full Text] [Related]
2. Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival.
Gerring RC; Ott CT; Curry JM; Sargi ZB; Wester ST
Eye (Lond); 2017 Mar; 31(3):379-388. PubMed ID: 27768120
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
4. Extended orbital exenteration in the treatment of advanced periocular skin cancer with primary reconstruction with a galeacutaneous flap.
Kovacevic PT; Visnjic MM; Kovacevic TT; Radojkovic MR; Stojanovic MR
Scand J Plast Reconstr Surg Hand Surg; 2009; 43(6):325-9. PubMed ID: 19995251
[TBL] [Abstract][Full Text] [Related]
5. Multicentred international review of orbital exenteration and reconstruction in oculoplastic and orbit practice.
Zhang Z; Ho S; Yin V; Varas G; Rajak S; Dolman PJ; McNab A; Heathcote JG; Valenzuela A
Br J Ophthalmol; 2018 May; 102(5):654-658. PubMed ID: 28844052
[TBL] [Abstract][Full Text] [Related]
6. Subtotal Exenteration of the Orbit for Benign Orbital Disease.
Furdova A; Babal P; Zahorjanova P; Sekac J
J Craniofac Surg; 2020; 31(5):1367-1369. PubMed ID: 32224777
[TBL] [Abstract][Full Text] [Related]
7. Rapid Rehabilitation With Skin-Muscle Sparing Orbital Exenteration: A Single-Center Series.
Jayaprakasam A; Vahdani K; Rose GE; Saleh GM; Hussain B; Verity DH; Collin JRO
Ophthalmic Plast Reconstr Surg; 2021 Jan-Feb 01; 37(1):51-54. PubMed ID: 32379171
[TBL] [Abstract][Full Text] [Related]
8. Orbital exenteration: The 10-year Massachusetts Eye and Ear Infirmary experience.
Nagendran ST; Lee NG; Fay A; Lefebvre DR; Sutula FC; Freitag SK
Orbit; 2016 Aug; 35(4):199-206. PubMed ID: 27322708
[TBL] [Abstract][Full Text] [Related]
9. Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
Sagiv O; Ding S; Ferrarotto R; Glisson B; Altan M; Johnson F; Elamin Y; Thakar SD; Nagarajan P; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2019; 35(4):350-353. PubMed ID: 30365473
[TBL] [Abstract][Full Text] [Related]
10. Orbital exenteration: A 20-year experience from a tertiary center in Taiwan.
Wang WY; Liao SL; Wei YH
J Formos Med Assoc; 2021 Jul; 120(7):1493-1499. PubMed ID: 33191092
[TBL] [Abstract][Full Text] [Related]
11. Globe-sparing surgical treatment for periocular malignancies with anterior orbital invasion: a consecutive case series.
Bergmann MJ; de Keizer ROB; Paridaens D
Orbit; 2023 Oct; 42(5):536-544. PubMed ID: 36617852
[TBL] [Abstract][Full Text] [Related]
12. Orbital Exenteration to Manage Infiltrative Sinonasal, Orbital Adnexal, and Cutaneous Malignancies Provides Acceptable Survival Outcomes: An Institutional Review, Literature Review, and Meta-Analysis.
Hoffman GR; Jefferson ND; Reid CB; Eisenberg RL
J Oral Maxillofac Surg; 2016 Mar; 74(3):631-43. PubMed ID: 26475973
[TBL] [Abstract][Full Text] [Related]
13. Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.
Furdova A; Lukacko P
J Craniofac Surg; 2017 Jan; 28(1):e84-e87. PubMed ID: 27906855
[TBL] [Abstract][Full Text] [Related]
14. Orbital exenteration for advanced periorbital skin cancers: 20 years experience.
Nassab RS; Thomas SS; Murray D
J Plast Reconstr Aesthet Surg; 2007; 60(10):1103-9. PubMed ID: 17434350
[TBL] [Abstract][Full Text] [Related]
15. Orbital exenteration: results of an individualized approach.
Goldberg RA; Kim JW; Shorr N
Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):229-36. PubMed ID: 12918560
[TBL] [Abstract][Full Text] [Related]
16. Orbital exenteration in periorbital malignancies.
Roche P; Timon C
Surgeon; 2012 Aug; 10(4):189-93. PubMed ID: 22818275
[TBL] [Abstract][Full Text] [Related]
17. RECURRENT PERIOCULAR BASAL CELL CARCINOMA. CASE REPORT.
Prídavková Z; Bieliková A; Ferková N; Lysková D
Cesk Slov Oftalmol; 2021; 77(4):208-213. PubMed ID: 34507497
[TBL] [Abstract][Full Text] [Related]
18. Orbital exenteration: one size does not fit all.
Ben Simon GJ; Schwarcz RM; Douglas R; Fiaschetti D; McCann JD; Goldberg RA
Am J Ophthalmol; 2005 Jan; 139(1):11-7. PubMed ID: 15652823
[TBL] [Abstract][Full Text] [Related]
19. Orbital exenteration: a 13 year Manchester experience.
Rahman I; Cook AE; Leatherbarrow B
Br J Ophthalmol; 2005 Oct; 89(10):1335-40. PubMed ID: 16170127
[TBL] [Abstract][Full Text] [Related]
20. Periocular apocrine adenocarcinoma presenting as an orbital mass: clinicopathological features and management in four patients.
Koç İ; Kiratli H; Kapucu Y; Söylemezoğlu F
Eur J Ophthalmol; 2022 May; 32(3):1804-1809. PubMed ID: 34187188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
